Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

16
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

25
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

36
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
36
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

26
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
26
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

29
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

28
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Piperine inhibits NLRP3 inflammasome activation and alleviates inflammatory disease.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Multimodal atlas of single neuron metabolic electrophysiological coupling uncovers circadian rewiring.

iScience·2026
Same author

Pathogenic variants in ACTRT3 lead to male infertility characterized by fertilization defects.

Human reproduction (Oxford, England)·2026
Same author

Prevalence of operating room occupational health cluster: a systematic review and meta-analysis.

Frontiers in public health·2026
Same author

Arginine metabolism and the NF-ĸB pathway jointly regulate the airway inflammation in asthma mediated by ILC2s.

International immunopharmacology·2026
Same author

The effects of endophytic fungal metabolites from <i>Conyza blinii</i> on antioxidant capacity and healthspan in <i>Caenorhabditis elegans</i>.

Natural product research·2026

Related Experiment Video

Updated: Aug 22, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K

Minimal Invasive Thoracoscopic Mitral Valve Surgery.

Liurong Cheng1, Hongying Zhu1, Wenzhen Xing2

  • 1Hainan General Hospital, Hainan Province, China.

Brazilian Journal of Cardiovascular Surgery
|November 8, 2022
PubMed
Summary

The totally thoracoscopic mitral valve surgery is a safe and effective minimally invasive option for patients with mitral valve disease. This approach, performed by experienced surgeons, demonstrates high success rates and minimal complications.

Keywords:
AnticoagulantsCardiopulmonary BypassDisseminated Intravascular CoagulationFemoral ArteryHeart Valve DiseasesIntensive Care UnitsProstheses and ImplantsThoracoscopy

More Related Videos

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K

Related Experiment Videos

Last Updated: Aug 22, 2025

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
08:12

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

1.7K
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

4.0K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.8K

Area of Science:

  • Cardiovascular Surgery
  • Minimally Invasive Techniques
  • Thoracoscopic Procedures

Background:

  • Mitral valve (MV) disease requires effective treatment options.
  • Minimally invasive surgery offers potential benefits over traditional open-heart procedures.
  • The totally thoracoscopic approach is an evolving technique for MV disease.

Purpose of the Study:

  • To evaluate the feasibility, safety, and effectiveness of the totally thoracoscopic approach for mitral valve disease.
  • To assess the outcomes of this minimally invasive procedure performed by an experienced surgeon.

Main Methods:

  • Retrospective analysis of 96 consecutive patients undergoing minimally invasive MV procedures.
  • Procedures performed via a femoral artery-vein bypass using a two-port system.
  • Data collected included preoperative cardiac function, operative details, postoperative complications, and follow-up.

Main Results:

  • 96 patients (average age 49.7 years) were included, with no intraoperative conversion or death.
  • Average cardiopulmonary bypass time was 163.8 minutes; aortic cross-clamp time was 119.7 minutes.
  • The overall success rate of mitral valve repair at 1-year follow-up was 97.9%.

Conclusions:

  • The totally thoracoscopic mitral valve procedure is technically feasible and safe.
  • This minimally invasive approach is effective for treating mitral valve disease.
  • The procedure is recommended for wider clinical adoption by experienced surgeons.